The Pivotal Scientific Portfolio

Partnering for Growth: A New Chapter in Business Collaboration

Published: June 4, 2020

Pivotal Scientific advises Antibody BCN on its sale to CliniSciences

Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology companyย AbBcn S.L.ย (AntibodyBCN) to the French distribution companyย CliniSciences. Pivotal Scientific Limited represented AntibodyBCN in their search for a buyer. We introduced them to CliniSci, facilitating a B2B introduction. By using our network of companies seeking to acquire distributors, we made the crucial connection, aiding in the process of finding a suitable buyer for AntibodyBCN.

The acquisition will broaden CliniSciences product portfolio for customised production of antibodies and distribution.

AbBcn S.L. approached PSL for assistance in finding potential buyers. PSL used its extensive database and expert knowledge of the global biotech landscape, approached companies looking to buy and facilitated this introduction.

โ€œCompanies are reaching out to us regularly when looking to Merge, Acquire or wanting to investigate management buyouts. AbBcn S.L. reached out and we were able to find a suitable buyer very quickly for them. A great addition to CliniSciences portfolioโ€

Tim Bernard, CEO, Pivotal Scientific Limited

If you are looking to buy or sell a company, visit PSL`sย Mergers & Acquisitionsย page orย contact usย to find out how we can guide you through the process.

Stay Informed

Sign up to our newsletter for the latest Industry insights and new technologies.
Subscribe Here